HBP Share Price

Open 1.00 Change Price %
High 1.00 1 Day 0.00 0.00
Low 0.99 1 Week 0.04 4.17
Close 1.00 1 Month 0.04 4.17
Volume 21350 1 Year -0.98 -49.49
52 Week High 2.25
52 Week Low 0.70
HBP Important Levels
Resistance 2 1.01
Resistance 1 1.01
Pivot 1.00
Support 1 0.99
Support 2 0.99
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
TBE 0.03 0.00%
YRI 3.75 1.90%
ONC 0.62 -32.61%
ONC 0.62 -32.61%
ECA 14.70 -2.84%
More..
TSE Canada Top Gainers Stocks
TVI 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
PWC 0.10 25.00%
PWC 0.10 25.00%
CUM 0.90 13.92%
CUM 0.90 13.92%
BLU 0.35 12.90%
LSG 2.08 8.33%
More..
TSE Canada Top Losers Stocks
ONC 0.62 -32.61%
ONC 0.62 -32.61%
GBV 0.46 -24.59%
MNR 0.17 -15.00%
MNR 0.17 -15.00%
CTU-A 0.19 -9.52%
BAA 0.10 -9.09%
BAA 0.10 -9.09%
EXN 1.40 -8.50%
PNP 2.40 -8.05%
More..

Helix BioPharma Corp (TSE: HBP)

HBP Technical Analysis 4
As on 24th May 2017 HBP Share Price closed @ 1.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.66 & Sell for SHORT-TERM with Stoploss of 1.17 we also expect STOCK to react on Following IMPORTANT LEVELS.
HBP Target for May
1st Target up-side 1.11
2nd Target up-side 1.29
3rd Target up-side 1.48
1st Target down-side 0.59
2nd Target down-side 0.41
3rd Target down-side 0.22
HBP Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.helixbiopharma.com
HBP Address
HBP
305 Industrial Parkway South
Unit 3
Aurora, ON L4G 6X7
Canada
Phone: 905-841-2300
Fax: 905-841-2244
HBP Latest News
Tale of the Ticker: Helix Biopharma Corp (HBPCF) Moves on Volume   The Times   - 22nd May 17
Helix BioPharma Corp. Announces Fiscal Second Quarter 2017 Results and Closing ...   Marketwired (press release)   - 17th Mar 17
Helix BioPharma Corp. Announces CAR-T Poster Presentation at AACR Annual ...   Marketwired (press release)   - 23rd Jan 17
Helix BioPharma Corp. Presents Topline L-DOS47 Results at the 17th IASCLC ...   Marketwired (press release)   - 06th Dec 16
Helix BioPharma Corp. Subsidiary, Helix Polska Sp. z oo, Finalizes Grant ...   Marketwired (press release)   - 22nd Jul 16
Helix BioPharma Corp. Announces Agreement in Principle With National Research ...   Marketwired (press release)   - 19th Jul 16
Helix BioPharma Corp. Announces L-DOS47 Immuno-Oncology Scientific ...   Marketwired (press release)   - 27th Jun 16
Helix BioPharma Corp. Opens the Market   MarketWatch   - 26th May 16
Helix BioPharma Corp. Closes CAD1.0 Million Private Placement   Marketwired (press release)   - 29th Apr 16
Helix BioPharma Corp. Announces CEO Change   Marketwired (press release)   - 30th Mar 16
Interactive Technical Analysis Chart Helix BioPharma Corp ( HBP TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Helix BioPharma Corp
HBP Business Profile
Helix BioPharma Corp., a biopharmaceutical company, develops drugs for the prevention and treatment of cancer based on its proprietary technologies. The company focuses on the development of L-DOS47 that is in phase I/II clinical trial for the treatment of inoperable, locally advanced, and recurrent or metastatic non-small cell lung cancer; and Topical Interferon Alpha-2b, which has completed phase II study for the treatment of low-grade cervical lesions and ano-genital warts caused by human papilloma virus infections. It also offers DOS47, a patented oncology platform technology that derives a therapeutic pharmacological effect by acting upon a naturally occurring substance in the body. Helix BioPharma Corp. is based in Aurora, Canada.